Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.015 SEK | -1.15% | +14.98% | +7.72% |
Apr. 25 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
Mar. 21 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Sales 2024 * | 26.75M 2.45M | Sales 2025 * | 52.18M 4.78M | Capitalization | 342M 31.3M |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.79M | Net income 2025 * | -93M -8.52M | EV / Sales 2024 * | 9.23 x |
Net cash position 2024 * | 94.7M 8.67M | Net cash position 2025 * | 58M 5.31M | EV / Sales 2025 * | 5.44 x |
P/E ratio 2024 * |
-3.37
x | P/E ratio 2025 * |
-2.41
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB
1 day | -1.15% | ||
1 week | +14.98% | ||
Current month | +11.74% | ||
1 month | +8.16% | ||
3 months | -15.43% | ||
6 months | -60.59% | ||
Current year | +7.72% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.07 | +0.66% | 274 410 |
24-04-25 | 3.05 | +10.51% | 355,255 |
24-04-24 | 2.76 | 0.00% | 126,115 |
24-04-23 | 2.76 | -3.16% | 431,759 |
24-04-22 | 2.85 | +6.74% | 243,245 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:22 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.72% | 31.34M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+1.05% | 22.02B | |
-17.84% | 20.9B | |
-9.35% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- MVIR B Stock